Topoisomerase IIα content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines
- 2 December 1996
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 39 (3) , 192-198
- https://doi.org/10.1007/s002800050559
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: